| Dr David L Clinkenbeard, MD | |
|
520 3rd St Nw, Jamestown, ND 58401-2968 | |
| (701) 253-6300 | |
| (701) 253-6400 |
| Full Name | Dr David L Clinkenbeard |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 520 3rd St Nw, Jamestown, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871537498 | NPI | - | NPPES |
| 015432 | Other | ND | BCBS PROVIDER NUMBER |
| 260035038 | Other | ND | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 5548 (North Dakota) | Primary |
| Entity Name | South Central Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225075906 PECOS PAC ID: 2365420262 Enrollment ID: O20040708000481 |
News Archive
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report from the Institute of Medicine. Every year in the U.S., approximately 395,000 cases of cardiac arrest occur outside of a hospital setting, in which less than 6 percent survive. Approximately 200,000 cardiac arrests occur each year in hospitals, and 24 percent of those patients survive. Estimates suggest that cardiac arrest is the third leading cause of death in the U.S. behind cancer and heart disease.
An international study involving Monash physicists has confirmed a new approach to measure consciousness, potentially changing our understanding complex neurological problems.
Results published today in The New England Journal of Medicine from a Janssen Research & Development, LLC (Janssen)-sponsored Phase 2b trial showed up to 86 percent of patients with moderate to severe plaque psoriasis receiving guselkumab (CNTO 1959) achieved a Physician's Global Assessment (PGA) score of cleared psoriasis or minimal psoriasis at week 16, the study's primary endpoint.
NHS professionals at a North West trust have been shortlisted for the prestigious national Patient Safety Awards, following important work around rapid response for deteriorating patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David L Clinkenbeard, MD Po Box 2055, Jamestown, ND 58402-2055 Ph: (701) 253-6300 | Dr David L Clinkenbeard, MD 520 3rd St Nw, Jamestown, ND 58401-2968 Ph: (701) 253-6300 |
News Archive
In an innovative collaboration designed to speed the process of drug discovery, Pfizer, Inc. and the University of California, San Diego Health Sciences announced today that UC San Diego has joined the ranks of other top-tier life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation.
Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report from the Institute of Medicine. Every year in the U.S., approximately 395,000 cases of cardiac arrest occur outside of a hospital setting, in which less than 6 percent survive. Approximately 200,000 cardiac arrests occur each year in hospitals, and 24 percent of those patients survive. Estimates suggest that cardiac arrest is the third leading cause of death in the U.S. behind cancer and heart disease.
An international study involving Monash physicists has confirmed a new approach to measure consciousness, potentially changing our understanding complex neurological problems.
Results published today in The New England Journal of Medicine from a Janssen Research & Development, LLC (Janssen)-sponsored Phase 2b trial showed up to 86 percent of patients with moderate to severe plaque psoriasis receiving guselkumab (CNTO 1959) achieved a Physician's Global Assessment (PGA) score of cleared psoriasis or minimal psoriasis at week 16, the study's primary endpoint.
NHS professionals at a North West trust have been shortlisted for the prestigious national Patient Safety Awards, following important work around rapid response for deteriorating patients.
› Verified 7 days ago
Dr. Eduardo P Yabut, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 520 3rd St Nw, Jamestown, ND 58401 Phone: 701-253-6300 Fax: 701-253-6400 | |
Dr. Ronald J Cavanagh, MD MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 520 3rd St Nw, Jamestown, ND 58401 Phone: 701-253-6325 Fax: 701-253-6400 | |
Dr. Clark Renwick Herniman, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2605 Circle Dr, Jamestown, ND 58401 Phone: 701-253-3650 | |
Dr. Alan J Broadhead, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 517 3 Ave Ne, Jamestown, ND 58401 Phone: 701-252-6300 Fax: 701-253-6400 | |
Dr. Maria Diana E. Robles, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 520 3rd St Nw, Jamestown, ND 58401 Phone: 701-253-6300 Fax: 701-253-6400 |